RPA1 and breast carcinoma: However, in contrast to gemcitabine-treated DLBCL cells, there was no shift for proteins in the ssDNA binding RPA complex or CHEK1 (Supplementary Fig. 7D) in cisplatin-treated breast cancer cells.